Welcome to the Newsroom
The IDOM Newsroom is your one stop place for announcements, news and events for the:
- Division of Endocrinology, Diabetes and Metabolism
- Institute for Diabetes, Obesity and Metabolism
- Diabetes Research Center
- Penn Rodebaugh Diabetes Center
Current News Features
Penn Researchers Offer New Approach to Treating Cocaine Addiction
University of Pennsylvania researchers Heath Schmidt, Matthew Hayes and Bart De Jonghe have shown that a drug used for diabetes and obesity may also reduce cocaine dependence.
A Pilot Intervention of a Type 1 Diabetes Pediatric to Adult Transitions Clinic in the Adult Healthcare System
The Enddocrine Society has selected Shivani Agarwal's abstract as on of the Helmsley Charitable Trust Abstract Awards in Type 1 Diabetes in conjunction with ENDO 2016 in Boston, MA.
Insulin Price Shock
Mark Schutta, MD, medical director of th Penn Rodebaugh Diabetes Center, and his patient Jeff Bargull are quoted in an article in the The Philadelphia Inquirer that covered the rising cost of insulin for those with diabetes and the effect these drugs prices have on patients.
Rob Kardashian Reportedly Hospitalized for Diabetes
Mitchell A. Lazar, MD, PhD, chief of the division of Endocrinology, Diabetes and Metabolism, commented on the symtoms, effects, and diagnosis of adult Type 1 and Type 2 diabetes, in a Yahoo! Health article about Rob Kardashian's recent Type 2 diabetes diagnosis.
Intranasal Glucagon Effective for Hypoglycemia in Type 1 Diabetes
Michael R. Rickels, MD, MS, medical director of Penn's Pancreatic Islet Cell Transplant Program, disucssed with Endocrinology Advisor the effective use of intranasal glucagon - nasal spray - for the treatment of hypoglycemia in patients with Type 1 diabetes.